This was trading at $15.85 less than a year ago. It's main drug candidate is a year closer to approval and the company is closer than that to a partnership.
Use a little common sense and buy a few shares before the gap-up.
back to .20/C and revers split again and again.?! that the poor people make money by losing. i should have bought some clothing for the kids. forget about kids college in buying stocks.selling mine now to buy some loaf of bread maybe some butter.
Listen to XOMA Ltd. Second Quarter 2010 Financial Results Conference Call (8/9/2010) for an overview of the situation:
"XOMAD should be above $5.00 here."
“Last week’s 1 – 15 reverse split is impacting the share price.”
“Current price is equal to about 20 cents pre-split.”
“52 week high was $15.85 on a post split basis. Bottomed at $3.02 on Friday.”
"Current market cap is only $63 million. Companies with no track record of product development and a similar drug in the pipeline are valued at many times what XOMA is currently."
“GSK needs a replacement for Avandia. Potential suitor.”
“Company is currently self-funded through the next 12 months with almost $100,000,000 in revenues.”
"Buy it before the gap-up."
"Partnership announcement takes it above $10.00."
“Due diligence but do buy a few shares here.”
I'm not being mean but I am wondering how long have you been following XOMAD? I am buying more shares too but it seems to keep pulling back every day. Just pulled to $3.04 aftr. hrs. Very hard to keep buying now. But you have a great comment though.